A B S T R A C T The circulatory effects of selective metabolic inhibition of glycolysis and of the tricarboxylic acid cycle by iodoacetate and fluoroacetate were studied in intact chloralose-anesthetized dogs. Pulmonary arterial blood pressure and vascular resistance increased after administration of both inhibitors, but neither systemic hemodynamics nor myocardial contractility changed significantly. Coronary blood flow did not change after iodoacetate administration but increased four-to fivefold after fluoroacetate. Administration of normal saline had no effect on any of the parameters. The changes in pulmonary arterial blood pressure and coronary blood flow after fluoroacetate were not mediated via the autonomic nerves or adrenergic neurohumors because they still occurred after autonomic nervous system inhibition. Neither myocardial oxygen consumption nor left ventricular work changed. A selective increase in myocardial blood flow also occurred in conscious dogs after fluoroacetate administration; hepatic artery flow was reduced, but other organ flows did not change significantly. These results indicate that pulmonary pressor and coronary dilator effects may be produced in intact dogs by selective metabolic blockade, in the absence of reduced oxygen supply or impairment in the electron transport system. These results also suggest that the increases in pulmonary arterial blood pressure, coronary blood flow, and cardiac output that occur during hypoxia probably are related to separate metabolic events in the tissue.
INTRODUCTION
The increases in cardiac output and coronary blood flow in intact animals which occur during arterial hypoxemia are associated not only with a reduction in tissue oxygen tension but also with a variety of metabolic changes. Cardiac output and coronary blood flow also may increase in the absence of any reduction in tissue oxygen tension when metabolic changes like those occurring in hypoxia are produced by cyanide (1, 2) . Thus, these hemodynamic changes could be attributed, at least in part, to alterations in metabolite contents typical ofhypoxia. The metabolites or portions of the metabolic systems that initiate the circulatory stimulation, however, are not known, partly because virtually all tissue metabolic processes are affected by the inhibitory actions of hypoxia and cyanide on the electron transport system. In the present experiments, attempts were made to produce more selective metabolic blockade, to ascertain whether changes in cardiac output and coronary blood flow are associated with alterations in glycolytic and tricarboxylic acid cycle activities.
METHODS
Adult male dogs weighing [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] kg after overnight fast were anesthetized with intravenous chloralose (60 mg/kg) after induction with vaporized halothane (Fluothane, Ayerst Laboratories, New York). The trachea was cannulated with a T-tube connected to a Benedict-Roth spirometer filled with 100% oxygen to record the rate of oxygen consumption. (3, 4) . Diastolic coronary vascular resistance (CVRd), left ventricular work (LVW), myocardial oxygen consumption (MVO2), and index of mechanical efficiency (ME) were calculated as follows 1,100 00 MV02 (ml/100 g per min) = CBF x (CaO2 -CCS02) + 1,000; LVW ME (%) = .LV MVO2 x 2.06 where Adm is arterial mean diastolic pressure, mm Hg; CVm, coronary venous mean pressure, mm Hg; CBF, coronary blood flow, ml/100 g/min; DFP, coronary diastolic inflow period, s/min; LVsm, left ventricular systolic mean pressure, mm Hg; CO, cardiac output, liters/min; CaO2; femoral arterial oxygen content, ml/liter; CcsO2, coronary sinus oxygen content, ml/liter.
Arterial and coronary sinus venous blood samples were taken for measuring pH on a Radiometer PHM71 AcidBase Analyzer (The London Co., Westlake, Ohio), 02 content (6), calcium (7), lactate (8) , pyruvate (9), glucose (10) , and free fatty acids (11) . Myocardial extraction coefficients and utilization rates of the substrates were calculated.
Glycolytic inhibition was produced in eight dogs by intravenous infusion of a neutral 5% sodium iodoacetate solution (25 (14) , and serial intravenous injections ofnorepinephrine before drug pretreatment and 60 min after fluoroacetate administration.
Finally, fluoroacetate (2 mg/kg) was administered to six conscious dogs to avoid the possible effects of anesthetic agents on the cardiac output response to fluoroacetate. Blood flows to various organs were also studied by the radioactive microsphere method of Rudolph and Heymann (15) . The animals were sedated with morphine sulfate (1 mg/kg subcutaneously) and instrumented for measuring cardiac output as previously described for the anesthetized dogs, except their vessels were cannulated under local lidocaine (Xylo- manganese-54 at a specific activity of 10 mCi/g, were used. To determine organ blood flows, 450,000 microspheres were injected into the left ventricle via a catheter, which was immediately flushed with 10 ml of normal saline over a 30-s period. Arterial reference blood was withdrawn with a Harvard pump (Harvard Apparatus Co., Inc., Millis, Mass.) at a rate of 7.75 ml/min, beginning 10 s before the injection of microspheres and continuing for 80 s thereafter. At the end of the experiment, the dog was sacrificed with intravenous sodium pentobarbital; the lungs, heart, brain, kidneys, liver, stomach, small intestine, large intestine, spleen, pancreas, urinary bladder, ureters, adrenal glands, skeletal muscle, femur, and skin were removed, cleaned, and weighed. After the organs had been ashed in an oven, their content of radioactivity was measured in a Packard gamma spectrometer (Packard Instrument Co., Inc., Downers Grove, Ill.) at the appropriate gamma photon energy for each of the two radionuclides. Absolute blood flow to each organ and tissue was calculated on a PDP-11/10 minicomputer (Digital Equipment Corp., Marlboro, Mass.) by the reference sample method (16) as follows: Organ flow (ml/100 g per min) = Arterial reference flow (ml/min) x organ nuclide activity x 100/Arterial reference nuclide activity x organ weight (g).
Experimental results were analyzed by analysis of variance for repeated measures (17) and the statistical significance of differences between the control and experimental values was determined by Dunnett's test (18 
RESULTS
Glycolytic blockade by iodoacetate. lodoacetate increased concentrations of fructose-1,6-diphosphate, glyceraldehyde-3-phosphate, and dihydroxyacetone phosphate in arterial whole blood and skeletal mtuscle (Fig. 1) . Both pulmonary arterial blood pressure and vascular resistance increased (Fig. 2) , but neither systemic nor coronary hemodynamics changed significantly (Fig. 2, Table I ). Furthermore, iodoacetate infusion did not change total body oxygen consumption significantly (126+5-136+9 ml/min).
Cardiac metabolism was not affected significantly by iodoacetate, as determined by myocardial extraction coefficients of oxygen, lactate, glucose, and free fatty acids (Table II (Table I) or cardiac metabolism (Table  II) .
Tricarboxylic acid cycle inhibition by fluoroacetate.
Blood and skeletal muscle citrate concentrations increased after fluoroacetate administration (Fig. 3) . Likewise, cardiac citrate concentration 60 min after fluoroacetate administration (0.44±0.05 ,mol/g fresh weight, n = 7) was significantly higher than the control value (0.27±0.02 ,umol/g fresh weight, n = 5). Like iodoacetate, fluoroacetate produced increases in pulmonary arterial blood pressure and vascular resistance, and had no significant effects on total body oxygen consumption (124±5-124+6 ml/min) and systemic hemodynamic parameters, except for a small decrease in systemic arterial blood pressure at 1 h (Fig. 4) .
On the other hand, coronary blood flow markedly increased after administration of fluoroacetate, accompanied by a reduction in diastolic coronary vascular resistance (Table I, Fig. 5 ). Coronary sinus oxygen content increased to 350% of the control with a marked reduction in myocardial oxygen extraction (Table I) , but myocardial oxygen consumption did not change (Table I, Fig. 5 ). In addition, neither left ventricular work nor the index of myocardial efficiency changed significantly (Table I) .
Cardiac metabolism was markedly influenced by fluoroacetate (Table II) . Coronary sinus blood pH increased, but arterial blood pH did not change significantly. Fluoroacetate increased arterial blood lactate concentration and decreased arterial plasma free fatty acid concentration. The myocardial extraction coefficients of lactate, pyruvate, glucose, and free fatty acids all fell, but the rate of myocardial utilization oflactate increased. There was no change in myocardial utilization of pyruvate and glucose, but the rate of myocardial utilization of free fatty acids was reduced. Coronary sinus plasma calcium concentration, measured in nine dogs, did not change significantly after fluoroacetate administration (8.8±0.5-9.0±0.4 mgI100 ml).
Effects of autonomic nervous system inhibition on hemodynamic responses to fluoroacetate administration. Mecamylamine pretreatment reduced the pressor response to common carotid occlusion from 53±9 to 3±1 mm Hg (n = 5, P < 0.01). Propranolol pretreatment increased the dose of isoproterenol required to produce a rise in heart rate of 25 (19) . If iodoacetate is distributed evenly within the body, its concentration achievable in the present experiments would not have exceeded 0.3 mM, a concentration at which iodoacetate exerts a rather specific action on glycolysis (19) . The present results suggest that iodoacetate exerted no significant actions on the tricarboxylic acid cycle and on the electron transport system of the myocardium.
Fluoroacetate condenses with oxaloacetate in vivo to produce fluorocitrate which selectively and competitively inhibits citrate utilization by its action on aconitase (20) . At very large doses, fluorocitrate inhibits succinate dehydrogenase (21) , but it has no direct action on other enzymes or on oxidative phosphorylation (20) .
Arterial lactate concentration increased and myocardial utilization of free fatty acids was abolished after fluoroacetate administration. Similarly, it is known that a shift from fatty acid oxidation to increased glycolysis occurs during hypoxia (22) (23) (24) , probably partly because of the highly accelerated activity of phosphofructokinase (23) relative to that of thiokinase. However, neither total body nor myocardial oxygen consumption changes significantly in intact animals during mild to moderately severe hypoxia (25) (26) (27) (28) , partly because the increased flow compensates for the reduction in arterial oxygen content (26) . Likewise, oxygen consumption did not change after fluoroacetate administration in the present experiments. The partial inhibitory action offluoroacetate probably was offset by the increased citrate concentration (29) . The heart also may utilize glutamate and aspartate, which feed into the tricarboxylic acid cycle distal to the aconitase step. Administration of larger doses (4 mg/kg) of fluoroacetate caused periodic convulsion, lactic acidosis, and an increase in oxygen consumption (unpublished observation), making it difficult to interpret the hemodynamic changes.
A pulmonary pressor response to iodoacetate has been reported in isolated perfused lungs (30, 31) , indicating a direct action of iodoacetate on the lung. The present study demonstrates that both iodoacetate and fluoroacetate cause pulmonary vasoconstriction, and that the pulmonary pressor effect of fluoroacetate is not mediated by adrenergic mechanism.
The experiments with iodoacetate show that pulmonary vasoconstriction is correlated with the accumulation of glycolytic metabolites, in the absence ofreduced oxygen tension. Reduced production ofATP via the glycolytic pathway is expected, but aerobic metabolism and oxidative phosphorylation were not altered. These changes in glycolytic metabolites, which also occur during hypoxia (22, 23, 32) and after fluoroacetate administration (29) , may be responsible directly or indirectly for the pulmonary pressor response.
Coronary blood flow increased and diastolic coronary vascular resistance decreased after fluoroacetate administration. lodoacetate administration, however, had no effects on coronary circulation. The heart possesses a rapid metabolic rate, great dependence on aerobic metabolism (33) , and greater reliance on autoregulation of the flow than on neural control (34) . Whether fluoroacetate also increases the blood flow to exercising skeletal muscle which exhibits the same metabolic properties warrants further study. The coronary vascular effects of fluoroacetae probably were not mediated by the autonomic nerves or adrenergic neurohumors to the heart (35), because systemic hemodynamics and myocardial contractility did not change significantly and because vagotomy and sympathetic blockade did not abolish this coronary dilator response to fluoroacetate. The reduction in coronary blood flow after autonomic nervous system inhibition is consistent with the finding that coronary blood flow decreases after surgical cardiac denervation to one-half the value obtained in the normal dog (36) , indicating that the denervated heart functions at a lower metabolic rate than the heart with normal innervation.
Coronary flow increased after addition of fluoroace- (20, 37) . The kidney exhibits the highest citrate concentration in the body, whereas the citrate level in liver changes only slightly (20) . Renal blood flow did not change significantly 30 min after fluoroacetate administration. Farah, et al. (39) , by direct measurements with flowmeters, also found that renal Metabolic Control of Circulationblood flow changed relatively little in the first 30 min, but fell to 40-70% of the control 2-3h later. Hepatic arterial blood flow decreased. Similarly, it decreases during severe hypoxia, probably a result of adrenergic stimulation (40) . The increases in cardiac output and myocardial contractility during hypoxia probably are related to autoregulation ofthe peripheral vascular beds (41) and stimulation of the sympathetic nervous system (1, 28, 42, 43) . Results of the present study suggest that the systemic hemodynamic effects of hypoxia probably are not causally related to the accumulation of glycolytic metabolites or of other metabolites which are also affected by fluoroacetate. It also appears that the type and degree of the vascular responses are determined, at least in part, by the qualitative and quantitative differences in cellular enzymatic composition that exist in various organs. Further work is needed to determine the role of metabolically linked vasoactive substances (44) (45) (46) in the regulation of cardiac output and organ blood flows.
Note added in proof. Additional experiments were performed in collaboration with Dr. John M. Lowenstein to study the effects of fluoroacetate (2 mg/kg i.v.) on coronary sinus plasma and myocardial concentrations of adenosine, inosine, and hypoxanthine in five chloralose-anesthetized dogs. The purine nucleosides and hypoxanthine were measured as previously described by Schultz and Lowenstein (47) . Coronary sinus plasma concentrations of adenosine, inosine, and hypoxanthine were 0.12±0.05, 0.10±0.06, and 0.75±0.23,tmol/liter, respectively, before fluoroacetate administration, and were 0.11±0.05, 0.47±0.21, and 3.56±1. 36 ,umol/liter, respectively, 30 min after fluoroacetate administration. The changes in inosine and hypoxanthine concentrations were statistically significant at P < 0.05, as determined by the Student's t test for paired data. Simultaneously, myocardial adenosine concentrations increased to 444±45% ofthe control values. These results suggest that the increase in coronary blood flow produced by fluoroacetate probably was caused by the vasodilator action of adenosine released from the myocardium.
